{"id":1082054,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Below-Knee Amputation - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-20","captureTimestamp":"2026-03-20T21:33:05.566000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53777.html?wbdisable=true","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Below-Knee Amputation A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) What is the issue? Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of drugs used in the second- or…","rawSnapshotUrl":"/api/snapshots/raw/1082054","browseUrl":"https://replay.healtharchive.ca/job-8/20260320213305/https://cihr-irsc.gc.ca/e/53777.html?wbdisable=true#ha_snapshot=1082054","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}